We are live on
!
Find out more
AI
Accredited Investors Portfolio holdings
AUM
$2.31B
1-Year Est. Return
33.7%
This Fund
S&P 500
This Quarter
Est. Return
+6.03%
1 Year Est. Return
+33.7%
3 Year Est. Return
+74.04%
5 Year Est. Return
+69.22%
10 Year Est. Return
+269.29%
AUM
$361M
AUM Growth
-$861K
(-0.24%)
Cap. Flow
-$20.8M
Cap. Flow
% of AUM
-5.77%
Top 10 Holdings %
Top 10 Hldgs %
73.39%
Holding
127
New
10
Increased
42
Reduced
53
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$1.33M |
| 2 |
iShares Russell 2000 Value ETF
IWN
|
+$582K |
| 3 |
Meta Platforms (Facebook)
META
|
+$558K |
| 4 |
iShares Russell Mid-Cap Value ETF
IWS
|
+$390K |
| 5 |
Emerson Electric
EMR
|
+$364K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$4.46M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$1.79M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$1.78M |
| 4 |
Verizon
VZ
|
+$1.54M |
| 5 |
GE Aerospace
GE
|
+$1.44M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 5.4% |
| 2 | Technology | 3.43% |
| 3 | Consumer Staples | 3.23% |
| 4 | Healthcare | 2.34% |
| 5 | Financials | 2.02% |
Similar funds
CM
NDSIB
ABI
BWFA
FBIL
NSAM
LFM
MFAM
Accredited Investors's Q4 2017 Portfolio in Review
As of Q4 2017, Accredited Investors held 127 positions worth $361M, down 0.24% from $362M the previous quarter. Its ten largest holdings account for 73% of the portfolio.
Accredited Investors withdrew a net $20.8M in Q4 2017, closing 9 positions and reducing 53 holdings. Its most notable exit was GSK, an estimated $1.13M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 5.4% of assets, down from 5.7% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Accredited Investors opened a new position in iShares Russell 2000 Value ETF worth $586K.
- Accredited Investors's largest Q4 2017 buy was iShares Russell 2000 Value ETF: 4,659 shares worth $586K.
- Accredited Investors added most to UnitedHealth in Q4 2017, an estimated $1.33M increase.
- Accredited Investors's biggest Q4 2017 reduction was ExxonMobil, cutting an estimated $4.46M.
- Accredited Investors fully exited GSK in Q4 2017, selling an estimated $1.13M.
- Accredited Investors's ten largest holdings make up 73% of its $361M portfolio in Q4 2017.
- Accredited Investors opened 10 new positions and closed 9 in Q4 2017.
- Accredited Investors's portfolio value fell 0.24% quarter-over-quarter to $361M.
Based on Accredited Investors's 13F filing for Q4 2017, filed 17 Jan 2018.